Pharmacological properties of a wide array of ergolines at functional alpha1-adrenoceptor subtypes

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 376, Issue 5, 2008, Pages 321-330

  Görnemann, Tilo ^a   Jähnichen, Sven ^a,d   Schurad, Björn ^b   Latté, Klaus Peter ^b   Horowski, Reinhard ^b   Tack, Johannes ^b   Flieger, Miroslav ^c   Pertz, Heinz H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b axxonis Pharma AG   (Germany)

^c Alfarma sro ^*  (Czech Republic)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

1A Adrenoceptor; 1B Adrenoceptor; 1D Adrenoceptor; Contractile responses; Ergolines; Native 1 adrenoceptor subtypes

Indexed keywords

1 ALLYL 6 ETHYLNORTERGURIDE; 1 ALLYL 6 PROPYLNORTERGURIDE; 1 ALLYLDIHYDROERGOTAMINE; 1 ALLYLERGOTAMINE; 1 ALLYLLISURIDE; 1 ALLYLTERGURIDE; 1 METHYLLISURIDE; 1 METHYLTERGURIDE; 1,6 DIALLYLNORTERGURIDE; 6' DEOXO ALPHA ERGOCRYPTINE; 6' DEOXODIHYDROERGOTAMINE; 6' DEOXOERGOCRISTINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; DIDEHYDRODIPERGURIDE; DIDEHYDROMETERGURIDE; DIDEHYDROPIPERGURIDE; DIHYDROERGOTAMINE; DIPERGURIDE; ERGOCRISTINE; ERGOCRYPTINE; ERGOLINE DERIVATIVE; ERGOTAMINE; LISURIDE; METERGURIDE; PYRROGURIDE; TERGURIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GUINEA PIG; NONHUMAN; RECEPTOR AFFINITY; SPLEEN; THORACIC AORTA; VASCULAR RING;

ANIMALS; AORTA, THORACIC; ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOLINES; GUINEA PIGS; ISOMETRIC CONTRACTION; MALE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 37749041166     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0221-3     Document Type: Article

References (35)

1. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58
2. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136
3. 1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Eur J Pharmacol 27(535):234-242
4. Colpaert F (1987) Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology 26:1431-1440
5. 1B-adrenoceptors in mouse. Physiol Genomics 9:85-91
6. 1-adrenoceptor subtype mediating contraction of guinea-pig spleen. Eur J Pharmacol 260:211-220
7. Emilien G, Maloteaux JM, Geurts M, Hoogenberg K, Cragg S (1999) Dopamine receptors-physiological understanding to therapeutic intervention potential. Pharmacol Ther 84:133-156
8. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines, handbook of experimental pharmacology. vol. 33. Springer, Berlin, pp 283-335
9. Guimarães S, Moura D (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53:319-356
10. 1B-adrenoceptors are involved in noradrenaline-induced contractions of rat tail artery. Eur J Pharmacol 488:157-167
11. Jourdan G, Verwaerde P, Pathak A, Tran MA, Montastruc JL, Senard JM (2007) In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension-midodrine and dihydroergotamine. Fundam Clin Pharmacol 21:45-53
12. 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br J Pharmacol 120:819-826
13. Marano M, Kaumann AJ (1976) On the statistics of drug-receptor constants for partial agonists. J Pharmacol Exp Ther 198:518-525
14. Marien MR, Colpaert FC, Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 45:38-78
15. 2 agonists and antagonists. Brain Res 562:216-224
16. Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A (2002) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther 303:791-804
17. Peroutka S (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44:53-64
18. Pertz H, Eich E (1999) Ergot alkaloids and their derivatives as ligands for serotoninergic, dopaminergic, and adrenergic receptors. In: Kren V, Cvak L (eds) Ergot: the genus Claviceps. Harwood Academic Publishers, Amsterdam, pp 411-440
19. 1 receptors. Naunyn-Schmiedebergs Arch Pharmacol 374:215-22
20. Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL Jr, Perez DM (1995) The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther 275:1583-1589
21. Roquebert J, Demichel P (1985) α-Adrenergic agonist and antagonist activity of dihydroergotoxine in rats. J Pharm Pharmacol 37:415-420
22. Roquebert J, Demichel P (1987) Agonist/antagonist activity of ergocristine at α-adrenoceptors in the rat. Fundam Clin Pharmacol 1:23-33
23. Roquebert J, Malek A, Gomond P, Demichel P (1984) Effect of dihydroergocristine on blood pressure and activity at peripheral α-adrenoceptors in pithed rats. Eur J Pharmacol 97:21-27
24. 1-adrenergic receptors by vessel bed and age. Circulation 100:2336-2343
25. Sanders-Busch E, Mayer SE (2005) 5-Hydroxytryptamine (serotonin): receptor agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman & Gilman's the pharmacological basis of therapeutics. 11st edn. McGraw-Hill, New York, pp 297-315
26. Saper JR, Silberstein S (2006) Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache 46(Suppl 4):S171-S181
27. 1 receptors in isolated arteries of rat and guinea pig. J Anim Sci 79:2202-2209
28. Tfelt-Hansen P, Saxena PR, Dahlof C, Pascual J, Lainez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ (2000) Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 123(Pt 1):9-18
29. 1-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomised dogs. Naunyn-Schmiedebergs Arch Pharmacol 370:46-53
30. 1-adrenoceptor antagonists in rat aorta. Br J Pharmacol 118:299-310
31. Vargas HM, Zhou L, Gorman AJ (1994) Role of vascular alpha-1 adrenoceptor subtypes in the pressor response to sympathetic nerve stimulation in the pithed rat. J Pharmacol Exp Ther 271:748-754
32. 2-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation. Br J Pharmacol 132:1292-1298
33. Willems EW, Valdivia LF, Villalón CM, Saxena PR (2003) Possible role of alpha-adrenoceptor subtypes in acute migraine therapy. Cephalalgia 23:245-257
34. 1D-adrenoceptors have a role in the pressor response to phenylephrine in the pithed rat. Eur J Pharmacol 305:173-176
35. 1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat Med 6:1388-1394